Moderna leads the development of mRNA vaccines in infectious diseases

Retrieved on: 2024-01-29 16:46:27

Tags for this article:

RNA vaccines

Medical research

COVID-19 vaccination in the United States

Deployment of COVID-19 vaccines

Herpes simplex research

Click the tags to see associated articles and topics

Moderna leads the development of mRNA vaccines in infectious diseases. View article details on HISWAI: https://www.pharmaceutical-technology.com/analyst-comment/moderna-leads-the-development-of-mrna-vaccines-in-infectious-diseases/

Summary

The article discusses the burgeoning field of mRNA vaccines beyond COVID-19, with Moderna leading in R&D. Business intelligence could help track and analyze the mRNA vaccine market's growth and diversification, inform investment decisions, and assess the public perception challenges faced by new vaccines. The tags denote the context of medical research and vaccine development in relation to specific companies and diseases.

Article found on: www.pharmaceutical-technology.com

View Original Article